ClinicalTrials.gov
public full text
Public Domain
BMS Reverse Cholesterol Transport (RCT) Study
The purpose of this study is to investigate the use of radiolabeled particulate cholesterol administered intravenously in association with albumin, as a method to study reverse cholesterol transport (RCT) in humans by analyzing changes in the tracer activity in total plasma, lipoproteins and feces.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)#1058771
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205#1008307
- Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis#897405
- Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males#897138
- A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body#123413
Record · ID 1338427
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive